Medical Care

Global Targeted Therapy For Kidney Disease Market Research Report 2025

The global market for Targeted Therapy For Kidney Disease was valued at US$ 122 million in the year 2024 and is projected to reach a revised size of US$ 174 million by 2031, growing at a CAGR of 5.3% during the forecast period.
Targeted therapy for kidney disease is a treatment method that intervenes by targeting specific molecules or pathological mechanisms of kidney disease. This therapy selectively targets pathogenic factors such as immune system abnormalities, inflammatory responses or cell damage according to different types of kidney disease, such as diabetic nephropathy and tubulointerstitial disease, to reduce side effects and improve treatment effects. Targeted therapy usually includes small molecule drugs, monoclonal antibodies, etc., which can effectively delay disease progression and improve renal function, and is an important direction for modern kidney disease treatment.
North American market for Targeted Therapy For Kidney Disease is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Targeted Therapy For Kidney Disease is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Targeted Therapy For Kidney Disease in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Targeted Therapy For Kidney Disease include AstraZeneca, Pfizer, Amgen, FibroGen, GlaxoSmithkline, AbbVie, Akebia Therapeutics, Teva Pharmaceutical Industries, Johnson & Johnson, Roche, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Targeted Therapy For Kidney Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Therapy For Kidney Disease.
The Targeted Therapy For Kidney Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Targeted Therapy For Kidney Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted Therapy For Kidney Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Pfizer
Amgen
FibroGen
GlaxoSmithkline
AbbVie
Akebia Therapeutics
Teva Pharmaceutical Industries
Johnson & Johnson
Roche
MicuRx
Everest Medicines
RemeGen
Segment by Type
ACE Inhibitors
Calcium Channel Blocker
Beta Blockers
Diuretics
Others
Segment by Application
Hospital
Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted Therapy For Kidney Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Therapy For Kidney Disease Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 ACE Inhibitors
1.2.3 Calcium Channel Blocker
1.2.4 Beta Blockers
1.2.5 Diuretics
1.2.6 Others
1.3 Market by Application
1.3.1 Global Targeted Therapy For Kidney Disease Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Therapy For Kidney Disease Market Perspective (2020-2031)
2.2 Global Targeted Therapy For Kidney Disease Growth Trends by Region
2.2.1 Global Targeted Therapy For Kidney Disease Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Targeted Therapy For Kidney Disease Historic Market Size by Region (2020-2025)
2.2.3 Targeted Therapy For Kidney Disease Forecasted Market Size by Region (2026-2031)
2.3 Targeted Therapy For Kidney Disease Market Dynamics
2.3.1 Targeted Therapy For Kidney Disease Industry Trends
2.3.2 Targeted Therapy For Kidney Disease Market Drivers
2.3.3 Targeted Therapy For Kidney Disease Market Challenges
2.3.4 Targeted Therapy For Kidney Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Therapy For Kidney Disease Players by Revenue
3.1.1 Global Top Targeted Therapy For Kidney Disease Players by Revenue (2020-2025)
3.1.2 Global Targeted Therapy For Kidney Disease Revenue Market Share by Players (2020-2025)
3.2 Global Top Targeted Therapy For Kidney Disease Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Targeted Therapy For Kidney Disease Revenue
3.4 Global Targeted Therapy For Kidney Disease Market Concentration Ratio
3.4.1 Global Targeted Therapy For Kidney Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Therapy For Kidney Disease Revenue in 2024
3.5 Global Key Players of Targeted Therapy For Kidney Disease Head office and Area Served
3.6 Global Key Players of Targeted Therapy For Kidney Disease, Product and Application
3.7 Global Key Players of Targeted Therapy For Kidney Disease, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Therapy For Kidney Disease Breakdown Data by Type
4.1 Global Targeted Therapy For Kidney Disease Historic Market Size by Type (2020-2025)
4.2 Global Targeted Therapy For Kidney Disease Forecasted Market Size by Type (2026-2031)
5 Targeted Therapy For Kidney Disease Breakdown Data by Application
5.1 Global Targeted Therapy For Kidney Disease Historic Market Size by Application (2020-2025)
5.2 Global Targeted Therapy For Kidney Disease Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Targeted Therapy For Kidney Disease Market Size (2020-2031)
6.2 North America Targeted Therapy For Kidney Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Targeted Therapy For Kidney Disease Market Size by Country (2020-2025)
6.4 North America Targeted Therapy For Kidney Disease Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Therapy For Kidney Disease Market Size (2020-2031)
7.2 Europe Targeted Therapy For Kidney Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Targeted Therapy For Kidney Disease Market Size by Country (2020-2025)
7.4 Europe Targeted Therapy For Kidney Disease Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Therapy For Kidney Disease Market Size (2020-2031)
8.2 Asia-Pacific Targeted Therapy For Kidney Disease Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Targeted Therapy For Kidney Disease Market Size by Region (2020-2025)
8.4 Asia-Pacific Targeted Therapy For Kidney Disease Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted Therapy For Kidney Disease Market Size (2020-2031)
9.2 Latin America Targeted Therapy For Kidney Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Targeted Therapy For Kidney Disease Market Size by Country (2020-2025)
9.4 Latin America Targeted Therapy For Kidney Disease Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Therapy For Kidney Disease Market Size (2020-2031)
10.2 Middle East & Africa Targeted Therapy For Kidney Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Targeted Therapy For Kidney Disease Market Size by Country (2020-2025)
10.4 Middle East & Africa Targeted Therapy For Kidney Disease Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Targeted Therapy For Kidney Disease Introduction
11.1.4 AstraZeneca Revenue in Targeted Therapy For Kidney Disease Business (2020-2025)
11.1.5 AstraZeneca Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Targeted Therapy For Kidney Disease Introduction
11.2.4 Pfizer Revenue in Targeted Therapy For Kidney Disease Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Targeted Therapy For Kidney Disease Introduction
11.3.4 Amgen Revenue in Targeted Therapy For Kidney Disease Business (2020-2025)
11.3.5 Amgen Recent Development
11.4 FibroGen
11.4.1 FibroGen Company Details
11.4.2 FibroGen Business Overview
11.4.3 FibroGen Targeted Therapy For Kidney Disease Introduction
11.4.4 FibroGen Revenue in Targeted Therapy For Kidney Disease Business (2020-2025)
11.4.5 FibroGen Recent Development
11.5 GlaxoSmithkline
11.5.1 GlaxoSmithkline Company Details
11.5.2 GlaxoSmithkline Business Overview
11.5.3 GlaxoSmithkline Targeted Therapy For Kidney Disease Introduction
11.5.4 GlaxoSmithkline Revenue in Targeted Therapy For Kidney Disease Business (2020-2025)
11.5.5 GlaxoSmithkline Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Targeted Therapy For Kidney Disease Introduction
11.6.4 AbbVie Revenue in Targeted Therapy For Kidney Disease Business (2020-2025)
11.6.5 AbbVie Recent Development
11.7 Akebia Therapeutics
11.7.1 Akebia Therapeutics Company Details
11.7.2 Akebia Therapeutics Business Overview
11.7.3 Akebia Therapeutics Targeted Therapy For Kidney Disease Introduction
11.7.4 Akebia Therapeutics Revenue in Targeted Therapy For Kidney Disease Business (2020-2025)
11.7.5 Akebia Therapeutics Recent Development
11.8 Teva Pharmaceutical Industries
11.8.1 Teva Pharmaceutical Industries Company Details
11.8.2 Teva Pharmaceutical Industries Business Overview
11.8.3 Teva Pharmaceutical Industries Targeted Therapy For Kidney Disease Introduction
11.8.4 Teva Pharmaceutical Industries Revenue in Targeted Therapy For Kidney Disease Business (2020-2025)
11.8.5 Teva Pharmaceutical Industries Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Details
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Targeted Therapy For Kidney Disease Introduction
11.9.4 Johnson & Johnson Revenue in Targeted Therapy For Kidney Disease Business (2020-2025)
11.9.5 Johnson & Johnson Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Targeted Therapy For Kidney Disease Introduction
11.10.4 Roche Revenue in Targeted Therapy For Kidney Disease Business (2020-2025)
11.10.5 Roche Recent Development
11.11 MicuRx
11.11.1 MicuRx Company Details
11.11.2 MicuRx Business Overview
11.11.3 MicuRx Targeted Therapy For Kidney Disease Introduction
11.11.4 MicuRx Revenue in Targeted Therapy For Kidney Disease Business (2020-2025)
11.11.5 MicuRx Recent Development
11.12 Everest Medicines
11.12.1 Everest Medicines Company Details
11.12.2 Everest Medicines Business Overview
11.12.3 Everest Medicines Targeted Therapy For Kidney Disease Introduction
11.12.4 Everest Medicines Revenue in Targeted Therapy For Kidney Disease Business (2020-2025)
11.12.5 Everest Medicines Recent Development
11.13 RemeGen
11.13.1 RemeGen Company Details
11.13.2 RemeGen Business Overview
11.13.3 RemeGen Targeted Therapy For Kidney Disease Introduction
11.13.4 RemeGen Revenue in Targeted Therapy For Kidney Disease Business (2020-2025)
11.13.5 RemeGen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Targeted Therapy For Kidney Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of ACE Inhibitors
Table 3. Key Players of Calcium Channel Blocker
Table 4. Key Players of Beta Blockers
Table 5. Key Players of Diuretics
Table 6. Key Players of Others
Table 7. Global Targeted Therapy For Kidney Disease Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Targeted Therapy For Kidney Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Targeted Therapy For Kidney Disease Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Targeted Therapy For Kidney Disease Market Share by Region (2020-2025)
Table 11. Global Targeted Therapy For Kidney Disease Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Targeted Therapy For Kidney Disease Market Share by Region (2026-2031)
Table 13. Targeted Therapy For Kidney Disease Market Trends
Table 14. Targeted Therapy For Kidney Disease Market Drivers
Table 15. Targeted Therapy For Kidney Disease Market Challenges
Table 16. Targeted Therapy For Kidney Disease Market Restraints
Table 17. Global Targeted Therapy For Kidney Disease Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Targeted Therapy For Kidney Disease Market Share by Players (2020-2025)
Table 19. Global Top Targeted Therapy For Kidney Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Therapy For Kidney Disease as of 2024)
Table 20. Ranking of Global Top Targeted Therapy For Kidney Disease Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Targeted Therapy For Kidney Disease Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Targeted Therapy For Kidney Disease, Headquarters and Area Served
Table 23. Global Key Players of Targeted Therapy For Kidney Disease, Product and Application
Table 24. Global Key Players of Targeted Therapy For Kidney Disease, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Targeted Therapy For Kidney Disease Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Targeted Therapy For Kidney Disease Revenue Market Share by Type (2020-2025)
Table 28. Global Targeted Therapy For Kidney Disease Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Targeted Therapy For Kidney Disease Revenue Market Share by Type (2026-2031)
Table 30. Global Targeted Therapy For Kidney Disease Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Targeted Therapy For Kidney Disease Revenue Market Share by Application (2020-2025)
Table 32. Global Targeted Therapy For Kidney Disease Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Targeted Therapy For Kidney Disease Revenue Market Share by Application (2026-2031)
Table 34. North America Targeted Therapy For Kidney Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Targeted Therapy For Kidney Disease Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Targeted Therapy For Kidney Disease Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Targeted Therapy For Kidney Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Targeted Therapy For Kidney Disease Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Targeted Therapy For Kidney Disease Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Targeted Therapy For Kidney Disease Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Targeted Therapy For Kidney Disease Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Targeted Therapy For Kidney Disease Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Targeted Therapy For Kidney Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Targeted Therapy For Kidney Disease Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Targeted Therapy For Kidney Disease Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Targeted Therapy For Kidney Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Targeted Therapy For Kidney Disease Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Targeted Therapy For Kidney Disease Market Size by Country (2026-2031) & (US$ Million)
Table 49. AstraZeneca Company Details
Table 50. AstraZeneca Business Overview
Table 51. AstraZeneca Targeted Therapy For Kidney Disease Product
Table 52. AstraZeneca Revenue in Targeted Therapy For Kidney Disease Business (2020-2025) & (US$ Million)
Table 53. AstraZeneca Recent Development
Table 54. Pfizer Company Details
Table 55. Pfizer Business Overview
Table 56. Pfizer Targeted Therapy For Kidney Disease Product
Table 57. Pfizer Revenue in Targeted Therapy For Kidney Disease Business (2020-2025) & (US$ Million)
Table 58. Pfizer Recent Development
Table 59. Amgen Company Details
Table 60. Amgen Business Overview
Table 61. Amgen Targeted Therapy For Kidney Disease Product
Table 62. Amgen Revenue in Targeted Therapy For Kidney Disease Business (2020-2025) & (US$ Million)
Table 63. Amgen Recent Development
Table 64. FibroGen Company Details
Table 65. FibroGen Business Overview
Table 66. FibroGen Targeted Therapy For Kidney Disease Product
Table 67. FibroGen Revenue in Targeted Therapy For Kidney Disease Business (2020-2025) & (US$ Million)
Table 68. FibroGen Recent Development
Table 69. GlaxoSmithkline Company Details
Table 70. GlaxoSmithkline Business Overview
Table 71. GlaxoSmithkline Targeted Therapy For Kidney Disease Product
Table 72. GlaxoSmithkline Revenue in Targeted Therapy For Kidney Disease Business (2020-2025) & (US$ Million)
Table 73. GlaxoSmithkline Recent Development
Table 74. AbbVie Company Details
Table 75. AbbVie Business Overview
Table 76. AbbVie Targeted Therapy For Kidney Disease Product
Table 77. AbbVie Revenue in Targeted Therapy For Kidney Disease Business (2020-2025) & (US$ Million)
Table 78. AbbVie Recent Development
Table 79. Akebia Therapeutics Company Details
Table 80. Akebia Therapeutics Business Overview
Table 81. Akebia Therapeutics Targeted Therapy For Kidney Disease Product
Table 82. Akebia Therapeutics Revenue in Targeted Therapy For Kidney Disease Business (2020-2025) & (US$ Million)
Table 83. Akebia Therapeutics Recent Development
Table 84. Teva Pharmaceutical Industries Company Details
Table 85. Teva Pharmaceutical Industries Business Overview
Table 86. Teva Pharmaceutical Industries Targeted Therapy For Kidney Disease Product
Table 87. Teva Pharmaceutical Industries Revenue in Targeted Therapy For Kidney Disease Business (2020-2025) & (US$ Million)
Table 88. Teva Pharmaceutical Industries Recent Development
Table 89. Johnson & Johnson Company Details
Table 90. Johnson & Johnson Business Overview
Table 91. Johnson & Johnson Targeted Therapy For Kidney Disease Product
Table 92. Johnson & Johnson Revenue in Targeted Therapy For Kidney Disease Business (2020-2025) & (US$ Million)
Table 93. Johnson & Johnson Recent Development
Table 94. Roche Company Details
Table 95. Roche Business Overview
Table 96. Roche Targeted Therapy For Kidney Disease Product
Table 97. Roche Revenue in Targeted Therapy For Kidney Disease Business (2020-2025) & (US$ Million)
Table 98. Roche Recent Development
Table 99. MicuRx Company Details
Table 100. MicuRx Business Overview
Table 101. MicuRx Targeted Therapy For Kidney Disease Product
Table 102. MicuRx Revenue in Targeted Therapy For Kidney Disease Business (2020-2025) & (US$ Million)
Table 103. MicuRx Recent Development
Table 104. Everest Medicines Company Details
Table 105. Everest Medicines Business Overview
Table 106. Everest Medicines Targeted Therapy For Kidney Disease Product
Table 107. Everest Medicines Revenue in Targeted Therapy For Kidney Disease Business (2020-2025) & (US$ Million)
Table 108. Everest Medicines Recent Development
Table 109. RemeGen Company Details
Table 110. RemeGen Business Overview
Table 111. RemeGen Targeted Therapy For Kidney Disease Product
Table 112. RemeGen Revenue in Targeted Therapy For Kidney Disease Business (2020-2025) & (US$ Million)
Table 113. RemeGen Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
Table 117. Authors List of This Report


List of Figures
Figure 1. Targeted Therapy For Kidney Disease Picture
Figure 2. Global Targeted Therapy For Kidney Disease Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Targeted Therapy For Kidney Disease Market Share by Type: 2024 VS 2031
Figure 4. ACE Inhibitors Features
Figure 5. Calcium Channel Blocker Features
Figure 6. Beta Blockers Features
Figure 7. Diuretics Features
Figure 8. Others Features
Figure 9. Global Targeted Therapy For Kidney Disease Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Targeted Therapy For Kidney Disease Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Pharmacy Case Studies
Figure 13. Targeted Therapy For Kidney Disease Report Years Considered
Figure 14. Global Targeted Therapy For Kidney Disease Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Targeted Therapy For Kidney Disease Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Targeted Therapy For Kidney Disease Market Share by Region: 2024 VS 2031
Figure 17. Global Targeted Therapy For Kidney Disease Market Share by Players in 2024
Figure 18. Global Targeted Therapy For Kidney Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Targeted Therapy For Kidney Disease Revenue in 2024
Figure 20. North America Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Targeted Therapy For Kidney Disease Market Share by Country (2020-2031)
Figure 22. United States Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Targeted Therapy For Kidney Disease Market Share by Country (2020-2031)
Figure 26. Germany Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Targeted Therapy For Kidney Disease Market Share by Region (2020-2031)
Figure 34. China Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Targeted Therapy For Kidney Disease Market Share by Country (2020-2031)
Figure 42. Mexico Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Targeted Therapy For Kidney Disease Market Share by Country (2020-2031)
Figure 46. Turkey Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Targeted Therapy For Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. AstraZeneca Revenue Growth Rate in Targeted Therapy For Kidney Disease Business (2020-2025)
Figure 50. Pfizer Revenue Growth Rate in Targeted Therapy For Kidney Disease Business (2020-2025)
Figure 51. Amgen Revenue Growth Rate in Targeted Therapy For Kidney Disease Business (2020-2025)
Figure 52. FibroGen Revenue Growth Rate in Targeted Therapy For Kidney Disease Business (2020-2025)
Figure 53. GlaxoSmithkline Revenue Growth Rate in Targeted Therapy For Kidney Disease Business (2020-2025)
Figure 54. AbbVie Revenue Growth Rate in Targeted Therapy For Kidney Disease Business (2020-2025)
Figure 55. Akebia Therapeutics Revenue Growth Rate in Targeted Therapy For Kidney Disease Business (2020-2025)
Figure 56. Teva Pharmaceutical Industries Revenue Growth Rate in Targeted Therapy For Kidney Disease Business (2020-2025)
Figure 57. Johnson & Johnson Revenue Growth Rate in Targeted Therapy For Kidney Disease Business (2020-2025)
Figure 58. Roche Revenue Growth Rate in Targeted Therapy For Kidney Disease Business (2020-2025)
Figure 59. MicuRx Revenue Growth Rate in Targeted Therapy For Kidney Disease Business (2020-2025)
Figure 60. Everest Medicines Revenue Growth Rate in Targeted Therapy For Kidney Disease Business (2020-2025)
Figure 61. RemeGen Revenue Growth Rate in Targeted Therapy For Kidney Disease Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies